ライフサイエンスコーパス: allogenic

1 antly greater than that of wounds containing allogenic ADM at 30 days after surgery.

2 Dispase-Triton-treated allogenic ADM was useful as a dermal substitute in full-

3 r surgery in wounds receiving xenogenic ADM, allogenic ADM, and thin STSGs.

4 ADM and moderately good in those containing allogenic ADM.

5 Xenogenic and allogenic ADMs were produced by treating porcine or rat

6 ally inhibit 2C TCR-mediated reactions to an allogenic agonist complex (QLSPFPFDL-L(d)), as well as t

7 ial is Clinical and Histological Outcomes of Allogenic Amnion Chorion Membrane in the Healing of Free

8 2 areas on their palates treated: 1 with an allogenic amnion-chorion membrane (ACM) and the other wi

9 ial aimed to compare the effectiveness of an allogenic amnion-chorion membrane (ACM) in promoting cli

10 t genotypic and phenotypic traits as well as allogenic and autogenic factors that shape microbiome co

11 munologically relevant assays and in vivo in allogenic and autoimmune models of islet transplantation

12 lammatory mediator of the immune response to allogenic and infectious stimuli.

13 topoietic progenitor cells that engrafted in allogenic and syngeneic recipient mice.

14 Allogenic and syngenic transplantation activate the HCMV

15 proving periodontal health using autogenous, allogenic, and xenogeneic grafting approaches.

16 for Breg subset markers and cocultured with allogenic anti-CD3-stimulated CD4(+) T cells, followed b

17 The role of SYK in allogenic antibody production is unknown, and we investi

18 1 Mvarphi showed stronger capacity to induce allogenic as well as Ag-specific (myelin oligodendrocyte

19 necessary adaptation to accommodate the semi-allogenic aspects of the fetoplacental unit does not com

20 inoculation of repeated doses of 2.5 x 10(7) allogenic AT-MSCs did not induce clinical or immunologic

21 lated from syngenic (Balb/C into Balb/C) and allogenic (Balb/C into C3H) transplants.

22 left anterior descending artery ligation in allogenic (BALB/c) mice.

23 for guided bone regeneration, autogenous and allogenic block grafts, and the application of distracti

24 Maternal shock, maternal requirement of allogenic blood product transfusion and lower gestationa

25 No patient required allogenic blood transfusion.

26 sis showed a significant association between allogenic blood transfusions and risk for developing VTE

27 t genetically induced deficiency of S1pr3 in allogenic BMDCs could serve as a therapeutic approach to

28 Notably, allogenic BMT recipients receiving either lethal or nonl

29 These data confirm that allogenic bone marrow transplantation establishes normal

30 t ways, to the genesis of chronic GVHD after allogenic bone marrow transplantation in a murine model.

31 Allogenic bone marrow transplantation was subsequently p

32 -versus-tumor (GVT) effect that occurs after allogenic bone marrow transplantation, previous attempts

33 of Epstein-Barr virus-induced lymphoma after allogenic bone marrow transplantation.

34 2 died 10 months later of complications from allogenic bone marrow transplantation.

35 %), umbilical cord blood stem cells (2; 4%), allogenic bone marrow-derived stem cells (1; 2%), placen

36 grafting the maxillary sinus with irradiated allogenic bone, 37 intact, vertical bone cores with a 2.

37 ol of alpha-myosin heavy chain promoter into allogenic C57BL/6 mice.

38 n-1 mAb prolonged survival of MLR mismatched allogenic cardiac grafts in primates.

39 Functionally, WNV-infected moDCs dampened allogenic CD4 and CD8 T cell activation and proliferatio

40 ppressed the proliferation of autologous and allogenic CD4(+)CD25(-) effector T cells.

41 re should provide new insights for improving allogenic cell-based therapies.

42 ial treatment option for patients lacking an allogenic compatible hematopoietic stem cell (HSC) donor

43 We then demonstrated that allogenic CP hESC-derived teratomas, fibroblasts, and ca

44 We suggest that either the allogenic CTL contained small, undetectable, EBV-specifi

45 ical trials of a living cellular sheet (LCS; allogenic cultured keratinocytes and fibroblasts in bovi

46 ells recognized not only autologous but also allogenic dendritic cells previously loaded with the rel

47 atment of full-thickness skin injuries as an allogenic dermal substitute providing a stable wound bas

48 Although the chimeric skin contains allogenic dermis, it is engraftable as long as autologou

49 nd cDNA (AdFasL), and were transplanted into allogenic diabetic hosts.

50 ue homing, and impaired effector function of allogenic donor T cells.

51 However the lack of a continued allogenic environment slows the process.

52 s of uncertainty suggest that the impacts of allogenic factors on rates of change during tropical for

53 The semi-allogenic fetoplacental unit has non-self components and

54 of achieving this result without substantial allogenic forcing.

55 etric observations, in concert, suggest that allogenic freeze-dried DBM has no adjunctive effect to G

56 esigned to evaluate the adjunctive effect of allogenic, freeze-dried, demineralized bone matrix (DBM)

57 (n = 5) compared with 240,896 +/- 87,042 in allogenic grafts (n = 9, P < 0.001) 12 weeks after trans

58 time, using our clinically relevant model of allogenic heart transplantation.

59 Depressed contractile function of rejecting allogenic heart transplants in vivo appears to be caused

60 rial infections are increasingly an issue in allogenic hematopoietic stem cell transplant patients.

61 g cause of morbidity and mortality following allogenic hematopoietic stem cell transplant.

62 ystitis (BKV-HC) is a common complication of allogenic hematopoietic stem cell transplantation (AHSCT

63 rbidity and nonrelapse mortality (NRM) after allogenic hematopoietic stem cell transplantation (allo-

64 Patients undergoing allogenic hematopoietic stem cell transplantation (allo-

65 threatening immunological complication after allogenic hematopoietic stem cell transplantation (allo-

66 Allogenic hematopoietic stem cell transplantation (HSCT)

67 ve treatment is a serious complication after allogenic hematopoietic stem cell transplantation (HSCT)

68 of AML patients >60 years of age undergoing allogenic hematopoietic stem cell transplantation at our

69 cipients, patients on anti-CD20 therapy, and allogenic hematopoietic stem cell transplantation recipi

70 potentially life-threatening complication of allogenic hematopoietic stem cell transplantation.

71 The only curative treatment is allogenic hematopoietic stem/progenitor cells (HSPCs) tr

72 aple syrup urine disease (iMSUD) model after allogenic hepatocyte transplantation, confirming that a

73 ls, the main reservoir of HTLV-I in vivo, or allogenic HLA-A2+ B cells pulsed with a known immunodomi

74 hymidine ((18)F-FLT) imaging was safe during allogenic HSCT and allowed visualisation of early cellul

75 th autologous HSCT, patients who received an allogenic HSCT without T-cell depletion were more likely

76 days to younger than 18 years, had undergone allogenic HSCT, and had been diagnosed with treatment-na

77 question mark however, may be autogenous or allogenic (i.e., either donor or recipient HLA-A24 or HL

78 e 2A receptor (A(2A)R) agonists to attenuate allogenic immune activation.

79 ey bottleneck to realizing such potential is allogenic immune rejection of hESC-derived cells by reci

80 strategy to protect hESC-derived cells from allogenic immune responses without requiring systemic im

81 ating various afferent and efferent limbs of allogenic immune responses.

82 c anti-4-1BB Abs enhances tumor immunity and allogenic immune responses.

83 This approach increases the efficacy of the allogenic infusion of human NK cells in mice injected wi

84 The therapeutic efficiency of allogenic/intrinsic neural stem cells (NSCs) after spina

85 74.1%+/-12.05% (thigh) viable beta cells in allogenic islet recipients.

86 ia associated with type 1 diabetes mellitus (allogenic islet transplantation), or the prevention of s

87 ning to metabolic outcomes of autologous and allogenic islet transplantation, shedding close light on

88 en-dependent efficacy in type 1 diabetes and allogenic islet transplantation.

89 ease during pre-clinical type 1 diabetes and allogenic islet transplantation.

90 patients who were successfully grafted with allogenic islets and determined that the appearance of d

91 survival at 2 years seems to be better than allogenic keratoplasty.

92 plasty viable alternative surgical option to allogenic keratoplasty.

93 Allogenic kidney transplants were performed using MIEP-l

94 etely blocked, whereas negative selection on allogenic MHC class II molecules remains intact.

95 or cells in both syngenic MHC-matched and in allogenic MHC-mismatched studies as C57BL/6 (H-2(b)) and

96 than 1% of T cells are activated by foreign (allogenic) MHC molecules, a phenomenon called alloreacti

97 xpressing islets under the kidney capsule of allogenic mice resulted in accelerated rejection identic

98 BMCs (YFP(+) and YFP(-)) was evaluated in an allogenic mixed lymphocyte reaction (MLR).

99 Either bradykinin solution (10(-5) M) or an allogenic mixture (adenosine 10(-3) M, bradykinin, hista

100 logy, and suppressed T-cell proliferation in allogenic MLR in a dose-dependent manner.

101 ignificantly lower proliferative response in allogenic MLR than the B cells from untreated patients.

102 ese iPSC lines do not activate T cells in an allogenic MLR; however, they express low levels of MHC c

103 l evidence for the safety and efficacy of an allogenic MSC-based intramammary therapy for the treatme

104 , we evaluated the safety and efficacy of an allogenic MSC-based intramammary therapy in dairy cows w

105 d in CD68 (+) cells from successful AVFs and allogenic MSC-treated mouse AVFs.

106 g AVFs created in mice and pigs treated with allogenic MSCs and xenotransplant using patient MSCs in

107 nstrate how direct and indirect contact with allogenic MSCs improves Tregs' potential for accumulatio

108 AVFs treated with allogenic MSCs in mice and pigs had an increase in M2- a

109 Transcriptomic analysis of AVFs treated with allogenic MSCs in mouse and MSC xenotransplants of patie

110 ning with no change in [Ca2+]i transients in allogenic myocytes, but had no effect in syngenic myocyt

111 hat were given small intestinal infusions of allogenic or autologous microbiota.

112 broader roles in ocular surface immunity and allogenic organ transplantation.

113 d have beneficial effects on the survival of allogenic organ transplants in mice and rats.

114 are able to mount in vivo responses against allogenic organs, resulting in tissue infiltration and r

115 thelial cells, and tissue destruction of the allogenic pancreata were observed in SCID-hu mice.

116 lospecific CTL can be isolated from rejected allogenic pancreata.

117 our group has shown that a GM-CSF-secreting allogenic pancreatic tumor cell vaccine (GVAX) may prime

118 t GVHD in dogs given growth factor mobilized allogenic PBSC might be altered in a beneficial way.

119 Sixteen rabbits underwent allogenic penetrating keratoplasty in one eye.

120 Allogenic platelet transfusions (PT) are administered to

121 In the second model, the allogenic potential of HFRPE cells was assessed, and in

122 lity and HMGB1 release following exposure to allogenic RBCs were conducted under static conditions an

123 Grafts were then transplanted into allogenic recipients +/- treatment with leukocyte functi

124 Two days after tracheal transplantation, allogenic recipients developed a persistent audible stri

125 re harvested and placed heterotopically into allogenic recipients.

126 ults indicate that A(2A)R agonists attenuate allogenic recognition by action on both T lymphocytes an

127 acles such as the control of stem cell fate, allogenic rejection and limited cell availability must b

128 n of remyelination produced by transplanting allogenic Schwann cells into demyelinated lesions in adu

129 Sclera was reconstructed with allogenic scleral grafts.

130 ents <65 years old at diagnosis who received allogenic SCT (n = 190) or conventional therapies (n = 2

131 PSS) model, the relative risk of death after allogenic SCT vs those treated with nontransplant modali

132 iate-2 or high-risk PMF clearly benefit from allogenic SCT.

133 tive CD8(+) T cell activation was induced by allogenic skin engraftment in both animal groups.

134 The allogenic spleen seems to show a protective effect on sm

135 The capacity of DC to stimulate allogenic splenocyte proliferation was also enhanced by

136 ugh most studies have used VSTs derived from allogenic stem cell donors, the use of banked VSTs deriv

137 or T-cell therapy, as well as the utility of allogenic stem cell transplantation and novel therapies,

138 outcomes of donor lymphocyte infusion after allogenic stem cell transplantation are heterogenous and

139 In contrast to the curative effect of allogenic stem cell transplantation in acute myeloid leu

140 JAK inhibitors, pomalidomide) drug therapy, allogenic stem cell transplantation with reduced- or con

141 ase (GVHD) is a major source of morbidity in allogenic stem cell transplantation.

142 sidual disease (>/=10(-4) cells) received an allogenic stem-cell transplant.

143 ells are tested for reactivity to a panel of allogenic stimulator cells by the IFN-gamma enzyme-linke

144 cytes were incubated ex vivo with irradiated allogenic stimulator cells in a mixed lymphocyte reactio

145 from control DCs in their ability to promote allogenic T cell proliferation in MLR in vitro.

146 ngerin-positive cells and are able to induce allogenic T cell proliferation.

147 endotoxin Hsp70, their ability to stimulate allogenic T cells was reduced.

148 -specific Tregs inhibit the proliferation of allogenic T cells, act in a cell-to-cell contact depende

149 ponse and reducing their ability to activate allogenic T cells.

150 ines and did not exert inhibitory effects on allogenic T cells.

151 ith autologous or MART1-specific HLA-matched allogenic TILs.

152 of myocardial infarction and corneal injury/allogenic transplant.

153 ents with sickle cell disease who receive an allogenic transplantation at age 12 years or younger and

154 ), and 3 patients in molecular relapse after allogenic transplantation became transiently polymerase

155 dence of a graft-versus-myeloma effect after allogenic transplantation.

156 cells that confers immunologic advantage for allogenic transplantation.

157 ays can activate the enhancer in response to allogenic transplantation.

158 through endogenous recruitment or autologous/allogenic transplantation.

159 for susceptibility factors to infections in allogenic transplantation.

160 on, PD monkeys receiving autologous, but not allogenic, transplantation exhibited recovery from motor

161 rom LBN (RT1(1+n) donors (group 2) and fully allogenic transplantations from ACI (RT1a) donors (group

162 Allograft rejection controls included semi-allogenic transplantations from LBN (RT1(1+n) donors (gr

163 Immune tolerance to allogenic transplanted tissues remains elusive, and ther

164 Isogenic and allogenic transplanted vehicle-treated animals (24/168 h

165 etween nonrejecting, syngenic and rejecting, allogenic transplants.

166 nts with severe bilateral LSCD necessitating allogenic transplants.

167 t were randomized to intravenous infusion of allogenic UC-MSCs (Cellistem, Cells for Cells S.A., Sant

168 cellularized hiPSC-derived TEVGs composed of allogenic vascular cells, potentially serving needs to a

169 Intracoronary infusion of allogenic Wharton's jelly derived mesenchymal stem cells

170 ized rhesus monkeys (two autologous and four allogenic) without immunosuppression using immunoisolato